NewsRx

Search our medical news database

Diagnostics

LXU Healthcare to exclusively distribute Ramp cardiovascular tests

Published in Medical Devices and Surgical Technology Week, January 1st, 2006

Response Biomedical Corp. (RBM, RPBIF) announced that it has appointed LXU Healthcare, Inc. as its exclusive distributor for the Ramp cardiovascular tests in a number of key markets in the U.S.

Response Biomedical has received U.S. Food & Drug Administration (FDA) and Canadian regulatory clearance for its fluorescence-based Ramp Reader for general clinical use and three Ramp cardiac marker tests for detecting troponin I, CK-MB and myoglobin. LXU Medical, LXU healthcare's medical-surgical division will also distribute the company's NT-proBNP test which is expected to be available towards the end of 2006.

These rapid quantitative tests assist in the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook